Aerobic exercise training in the treatment of non‐alcoholic fatty liver disease related fibrosis
Open accessThe DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.
Abstract
Key points: Physiologically relevant rodent models of non‐alcoholic steatohepatitis (NASH) that resemble the human condition are limited. Exercise training and energy restriction are first‐line recommendations for the treatment of NASH. Hyperphagic Otsuka Long–Evans Tokushima fatty rats fed a western diet high in fat, sucrose and cholesterol for 24 weeks developed a severe NASH with fibrosis phenotype. Moderate intensity exercise training and modest energy restriction provided some improvement in the histological features of NASH that coincided with alterations in markers of hepatic stellate cell activation and extracellular matrix remodelling. The present study highlights the importance of lifestyle modification, including exercise training and energy restriction, in the regulation of advanced liver disease. The incidence of non‐alcoholic steatohepatitis (NASH) is rising but the efficacy of lifestyle modifications to improve NASH‐related outcomes remain unclear. We hypothesized that a western diet (WD) would induce NASH in the Otsuka Long–Evans Tokushima Fatty (OLETF) rat and that lifestyle modification would improve this condition. Eight‐week‐old Long–Evans Tokushima Otsuka (L) and OLETF (O) rats consumed a control diet (10% kcal fat, 3.5% sucrose) or a WD (45% kcal fat, 17% sucrose, 1% cholesterol) for 24 weeks. At 20 weeks of age, additional WD‐fed OLETFs were randomized to sedentary (O‐SED), food restriction (O‐FR; ∼25% kcal reduction vs. O‐SED) or exercise training (O‐EX; treadmill running 20 m min–1 with a 15% incline, 60 min day–1, 5 days week–1) conditions for 12 weeks. WD induced a NASH phenotype in OLETFs characterized by hepatic fibrosis (collagen 1α1 mRNA and hydroxyproline content), as well as elevated inflammation and non‐alcoholic fatty liver disease activity scores, and hepatic stellate cell activation (α‐smooth muscle actin) compared to Long–Evans Tokushima Otsuka rats. FR and EX modestly improved NASH‐related fibrosis markers (FR: hydroxyproline content, P < 0.01; EX: collagen 1α1 mRNA, P < 0.05; both: fibrosis score, P < 0.01) and inflammation (both: inflammation score; FR: interleukin‐1β and tumor necrosis factor α) vs. O‐SED. FR reduced hepatic stellate cell activation markers (transforming growth factor‐β protein and α‐smooth muscle actin mRNA), whereas EX increased the hepatic stellate cell senescence marker CCN1 (P < 0.01 vs. O‐SED). Additionally, both FR and EX normalized extracellular matrix remodelling markers to levels similar to L‐WD (P > 0.05). Although neither EX nor FR led to complete resolution of the WD‐induced NASH phenotype, both independently benefitted liver fibrosis via altered hepatic stellate cell activation and extracellular matrix remodelling.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Excessive Loss of Skeletal Muscle Mass in Older Adults With Type 2 Diabetes
Park, S. W., Goodpaster, B. H., Lee, J. S., Kuller, L. H., Boudreau, R., de Rekeneire, N., Harris, T. B., Kritchevsky, S., Tylavsky, F. A., Nevitt, M., et al. (2009) · Diabetes Care · doi:10.2337/dc09-0264 · Cited by 778
Johnson, N. A., Sachinwalla, T., Walton, D. W., Smith, K., Armstrong, A., Thompson, M. W., & George, J. (2009) · Hepatology · doi:10.1002/hep.23129 · Cited by 631 · cited 2×
“Lifestyle modifications that induce weight loss (exercise training, reduced energy intake) are recommended for individuals with NAFLD (Caldwell & Lazo, 2009) and have been shown to improve simple steatosis (Larson-Meyer et al. 2008; Johnson et al. 2009; Elias et al. 2010; Lee et al. 2012; Linden et al. 2014; Linden et…”
BackgroundPradere, J.-P., Kluwe, J., De Minicis, S., Jiao, J.-J., Gwak, G.-Y., Dapito, D. H., Jang, M.-K., Guenther, N. D., Mederacke, I., Friedman, R., et al. (2013) · Hepatology · doi:10.1002/hep.26429 · Cited by 613 · cited 6×
“CCN1 can bind to TGF-β and lower SMAD signalling to prevent collagen deposition (Borkham-Kamphorst et al. 2014) and has been associated with endoplasmic reticulum stress-induced apoptosis of HSCs (Borkham-Kamphorst et al. 2016).”
BackgroundInfluentialBaeck, C., Wehr, A., Karlmark, K. R., Heymann, F., Vucur, M., Gassler, N., Huss, S., Klussmann, S., Eulberg, D., Luedde, T., et al. (2012) · Gut · doi:10.1136/gutjnl-2011-300304 · Cited by 609
Thoma, C., Day, C. P., & Trenell, M. I. (2012) · Journal of Hepatology · doi:10.1016/j.jhep.2011.06.010 · Cited by 523 · cited 1×
“One of the first recommendations for those diagnosed with NAFLD/NASH is to undergo a weight management programme (energy restriction, exercise training) and recent evidence suggests that 10% reductions in body weight are needed for histological improvements in NAFLD patients (Thoma et al. 2012).”
BackgroundStaels, B., Rubenstrunk, A., Noel, B., Rigou, G., Delataille, P., Millatt, L. J., Baron, M., Lucas, A., Tailleux, A., Hum, D. W., et al. (2013) · Hepatology · doi:10.1002/hep.26461 · Cited by 414 · cited 3×
“Methionine choline deficient diets (Ota et al. 2007; Vetelainen et al. 2007; Staels et al. 2013) or carbon tetrachloride (Baeck et al. 2012; Staels et al. 2013) induce fibrosis, although these models do not mimic the pathology observed in humans because they cause weight loss (Ota et al. 2007;…”
BackgroundLee, S., Bacha, F., Hannon, T., Kuk, J. L., Boesch, C., & Arslanian, S. (2012) · Diabetes · doi:10.2337/db12-0214 · Cited by 398
The role of TGFβ1 in initiating hepatic stellate cell activation in vivo
Hellerbrand, C., Stefanovic, B., Giordano, F., Burchardt, E. R., & Brenner, D. A. (1999) · Journal of Hepatology · doi:10.1016/s0168-8278(99)80010-5 · Cited by 393
Rector, R. S., Thyfault, J. P., Morris, R. T., Laye, M. J., Borengasser, S. J., Booth, F. W., & Ibdah, J. A. (2008) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00428.2007 · Cited by 321 · cited 4×
“These conditions can be prevented when OLETF rats are allowed to voluntary exercise on running wheels (Rector et al. 2008a; Rector et al. 2011; Linden et al. 2015).”
BackgroundMethodSelf-citationHabitual Physical Activity Is Associated With Intrahepatic Fat Content in Humans
Perseghin, G., Lattuada, G., De Cobelli, F., Ragogna, F., Ntali, G., Esposito, A., Belloni, E., Canu, T., Terruzzi, I., Scifo, P., et al. (2007) · Diabetes Care · doi:10.2337/dc06-2032 · Cited by 320
Kim, K.-H., Chen, C.-C., Monzon, R. I., & Lau, L. F. (2013) · Molecular and Cellular Biology · doi:10.1128/mcb.00049-13 · Cited by 261 · cited 4×
“2005) or the injection of CCN1 (Kim et al. 2013) was associated with increased gelatinase expression/activity and decreased TIMP-1 expression.”
BackgroundInfluentialBorkham-Kamphorst, E., Schaffrath, C., Van de Leur, E., Haas, U., Tihaa, L., Meurer, S. K., Nevzorova, Y. A., Liedtke, C., & Weiskirchen, R. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2014.01.023 · Cited by 105 · cited 3×
“CCN1 expression is increased within hepatocytes and HSCs during early liver injury and cirrhosis (Bian et al. 2013; Kim et al. 2013; Borkham-Kamphorst et al. 2014) and may have protective effects.”
BackgroundInfluentialRector, R. S., Uptergrove, G. M., Borengasser, S. J., Mikus, C. R., Morris, E. M., Naples, S. P., Laye, M. J., Laughlin, M. H., Booth, F. W., Ibdah, J. A., et al. (2010) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00703.2009 · Cited by 48
Self-citationIs exercise an effective treatment for NASH? Knowns and unknowns
Caldwell, S., & Lazo, M. (2009) · Annals of Hepatology · doi:10.1016/s1665-2681(19)31828-9 · Cited by 42 · cited 12×
“Hyperphagic OLETF rats develop NAFLD on a standard chow diet and, by 32–40 weeks of age, develop hepatocellular inflammation and mild hepatic perivenular fibrosis that is not observed in non-hyperphagic LETO control rats (Rector et al. 2011; Linden et al. 2015).”
BackgroundInfluential
Cited by
Nonalcoholic fatty liver disease as a nexus of metabolic and hepatic diseases
Samuel, V. T., & Shulman, G. I. (2018) · Cell Metabolism · doi:10.1016/j.cmet.2017.08.002 · Cited by 745
“Hyperphagic Otsuka Long-Evans Tokushima rats that are prone to developing NASH on aWestern diet only showmodest improvements in inflammation and fibrosis with 12 weeks of exercise training (Linden et al., 2016).”
The effects of physical exercise on fatty liver disease.
van der Windt, D. J., Sud, V., Zhang, H., Tsung, A., & Huang, H. (2018) · Gene Expression · doi:10.3727/105221617x15124844266408 · Cited by 294
Improvement in histological endpoints of MAFLD following a 12-week aerobic exercise intervention
O’Gorman, P., Naimimohasses, S., Monaghan, A., Kennedy, M., Melo, A. M., Ní Fhloinn, D., Doherty, D. G., Beddy, P., Finn, S. P., Moore, J. B., et al. (2020) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.15989 · Cited by 94
Bórquez, J. C., Díaz-Castro, F., La Fuente, F. P.-D., Espinoza, K., Figueroa, A. M., Martínez-Ruíz, I., Hernández, V., López-Soldado, I., Ventura, R., Domingo, J. C., et al. (2024) · Metabolism · doi:10.1016/j.metabol.2023.155765 · Cited by 54
Treating Hepatic Steatosis and Fibrosis by Modulating Mitochondrial Pyruvate Metabolism
McCommis, K. S., & Finck, B. N. (2019) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2018.09.017 · Cited by 39
Metadata
- Authors
- Linden, M. A., Sheldon, R. D., Meers, G. M., Ortinau, L. C., Morris, E. M., Booth, F. W., Kanaley, J. A., Vieira‐Potter, V. J., Sowers, J. R., Ibdah, J. A., Thyfault, J. P., Laughlin, M. H., & Rector, R. S.
- Venue
- The Journal of Physiology
- Publisher
- Wiley
- Published
- 2016-05-27
- Volume
- 594
- Issue
- 18
- Pages
- 5271-5284
- ISSN
- 0022-3751 (ISSN-L)
- 1469-7793
- OpenAlex
- W2515934247
- Cited by
- 68
- References
- 14
- FWCI
- 6.27
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.